M. Scot Roberts, Ph.D.

M. Scot Roberts, Ph.D.

Chief Scientific OfficeratAltimmune· In proxies 2024–2025

Pay in FY2025-10% from the year before · Altimmune stock -49.9% the same year

M. Scot Roberts, Ph.D. was paid $2.2M in FY2025 (Dec), down 10%. Altimmune stock fell 49.9% that year.

Pay$100 in the stock at the end of FY23 → $32
Pay is from the Summary Compensation Table of each Altimmune proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AltimmunePublic company · 2 yr
    • Chief Scientific Officer2024 – Present · 2 yrStock in role -81%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?